Report
Our reports provide latest industry trends, forecasts, company profiles, competitive landscape, and strategic insights.
Europe Infant, Child, and Maternal Probiotic Supplements Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Form (Capsules and Soft Gels, Gummies, Liquid, and Others) and End User (Infant and Toddler, Children, and Maternal Women)
- Report Code : BMIRE00027134
- Pages : 94
The Europe infant, child, and maternal probiotic supplements market is expected to grow from US$ 179.18 million in 2022 to US$ 287.30 million by 2028; it is estimated to grow at a CAGR of 8.2% from 2022 to 2028.
Pregnant women are seeking various alternatives to support their fitness and the health of their unborn babies. Digestive problems, such as constipation, diarrhea, acidity, and inflammation, are common during pregnancy. Recently, the demand for probiotic dietary supplements among pregnant women has increased. A thoroughly researched probiotic strains help improve bowel movement and relieve constipation problems. Consumption of probiotic supplements in the regular diet help reduce inflammation, acidity, and bloating, and it also lowers the risk of vaginal infections, thus decreasing the chances of colic, eczema, and other allergies in newborn babies. Further, it also reduces the risk of pre-eclampsia in pregnant women, a health condition resulting in high blood pressure and high protein levels in urine. Probiotic supplements also ensure better immunity for pregnant women, which helps fight chronic diseases and ensure the baby’s good health. Lactobacillus acidophilus, Bifidobacterium bifidum, and Saccharomyces boulardii are among the most effective and widely used probiotic strains in prenatal probiotic supplements. These strains help maintain a healthy intestinal flora and reduce the risk of various allergies, diseases, and complications, including gestational diabetes and pre-eclampsia. The growing awareness about the benefits of probiotic supplements among pregnant women and newborns is substantially driving the infant, child, and maternal probiotic supplements market growth.
With new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Europe infant, child, and maternal probiotic supplements market growth at a notable CAGR during the forecast period.
Europe Infant, Child, and Maternal Probiotic Supplements Market Revenue and Forecast to 2028 (US$ Million)
Europe Infant, Child, and Maternal Probiotic Supplements Market Segmentation
The market for Europe infant, child, and maternal probiotic supplements market is segmented into form, end user, and country. Based on form, the market is categorized into capsules and soft gels, gummies, liquid, and others. Based on end user, the market is segmented into infant and toddler, children, and maternal women. Based on country, the Europe infant, child, and maternal probiotic supplements market is segmented into Germany, the UK, France, Italy, Russia, and the Rest of Europe.
Europe Infant, Child, and Maternal Probiotic Supplements Market — Companies Mentioned
Bayer Corporation, Nestlé S.A., BioGaia AB, and Nordic Naturals are a few major companies operating in the Europe infant, child, and maternal probiotic supplements market.
TABLE OF CONTENTS
1. Introduction
1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
2. Key Takeaways
3. Research Methodology
3.1 Scope of the Study
3.2 Research Methodology
3.2.1 Data Collection:
3.2.2 Primary Interviews:
3.2.3 Hypothesis Formulation:
3.2.4 Macro-economic Factor Analysis:
3.2.5 Developing Base Number:
3.2.6 Data Triangulation:
3.2.7 Country Level Data:
3.2.8 Limitations and Assumptions:
4. Europe Infant, Child, and Maternal Probiotic Supplements Market Landscape
4.1 Market Overview
4.2 Porter’s Five Forces Analysis
4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes
4.3 Expert Opinion
4.4 Ecosystem Analysis
5. Europe Infant, Child, and Maternal Probiotic Supplements Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Demand for Probiotic Supplements in Paediatric Nutrition
5.1.2 Growing Awareness Regarding Benefits of Probiotic Supplements among Pregnant Women
5.2 Market Restraints
5.2.1 Consumer Perceptions on Probiotic Supplements for Newborn
5.3 Market Opportunities
5.3.1 Surging Demand in Developing Regions
5.4 Future Trends
5.4.1 Increasing Research and Development in Infant and Maternal Probiotics Space
5.5 Impact Analysis of Drivers and Restraints
6. Europe Infant, Child, and Maternal Probiotic Supplements –Market Analysis
6.1 Europe Infant, Child, and Maternal Probiotic Supplements Market –Revenue and Forecast to 2028 (US$ Thousand)
7. Europe Infant, Child, And Maternal Probiotic Supplements Market Analysis – By Form
7.1 Overview
7.2 Europe Infant, Child, And Maternal Probiotic Supplements Market, By Form (2021 and 2028)
7.3 Capsules and Softgels
7.3.1 Overview
7.3.2 Capsules and Softgels: Europe Infant, Child, And Maternal Probiotic Supplements Market – Revenue and Forecast to 2028 (US$ Thousand)
7.4 Gummies
7.4.1 Overview
7.4.2 Gummies: Europe Infant, Child, And Maternal Probiotic Supplements Market – Revenue and Forecast to 2028 (US$ Thousand)
7.5 Liquid:
7.5.1 Overview
7.5.2 Liquid: Europe Infant, Child, And Maternal Probiotic Supplements Market – Revenue and Forecast to 2028 (US$ Thousand)
7.6 Others
7.6.1 Overview
7.6.2 Others: Europe Infant, Child, And Maternal Probiotic Supplements Market– Revenue and Forecast to 2028 (US$ Thousand)
8. Europe Infant, Child, And Maternal Probiotic Supplements Market Analysis – By End User
8.1 Overview
8.2 Europe Infant, Child, And Maternal Probiotic Supplements Market, By End User (2021 and 2028)
8.3 Infant and Toddler
8.3.1 Overview
8.3.2 Infant and Toddler: Europe Infant, Child, And Maternal Probiotic Supplements Market – Revenue and Forecast to 2028 (US$ Thousand)
8.4 Children
8.4.1 Overview
8.4.2 Children: Europe Infant, Child, And Maternal Probiotic Supplements Market – Revenue and Forecast to 2028 (US$ Thousand)
8.5 Maternal Women
8.5.1 Overview
8.5.2 Maternal Women: Europe Infant, Child, And Maternal Probiotic Supplements Market – Revenue and Forecast to 2028 (US$ Thousand)
9. Europe Infant, Child, and Maternal Probiotic Supplements Market – Country Analysis
9.1 Europe: Infant, Child, and Maternal Probiotic Supplements Market
9.1.1 Europe: Europe Infant, Child, and Maternal Probiotic Supplements Market –Revenue and Forecast to 2028 (US$ Thousand)
9.1.2 Europe: Infant, Child, and Maternal Probiotic Supplements Market, by Key Country
9.1.2.1 Germany: Europe Infant, Child, and Maternal Probiotic Supplements Market – Revenue and Forecast to 2028 (US$ Thousand)
9.1.2.1.1 Germany: Infant, Child, and Maternal Probiotic Supplements Market, By Form
9.1.2.1.2 Germany: Infant, Child, and Maternal Probiotic Supplements Market, by End User
9.1.2.2 UK: Europe Infant, Child, and Maternal Probiotic Supplements Market – Revenue and Forecast to 2028 (US$ Thousand)
9.1.2.2.1 UK: Infant, Child, and Maternal Probiotic Supplements Market, By Form
9.1.2.2.2 UK: Infant, Child, and Maternal Probiotic Supplements Market, by End User
9.1.2.3 France: Europe Infant, Child, and Maternal Probiotic Supplements Market – Revenue and Forecast to 2028 (US$ Thousand)
9.1.2.3.1 France: Infant, Child, and Maternal Probiotic Supplements Market, By Form
9.1.2.3.2 France: Infant, Child, and Maternal Probiotic Supplements Market, by End User
9.1.2.4 Italy: Europe Infant, Child, and Maternal Probiotic Supplements Market – Revenue and Forecast to 2028 (US$ Thousand)
9.1.2.4.1 Italy: Infant, Child, and Maternal Probiotic Supplements Market, By Form
9.1.2.4.2 Italy: Infant, Child, and Maternal Probiotic Supplements Market, by End User
9.1.2.5 Russia: Europe Infant, Child, and Maternal Probiotic Supplements Market – Revenue and Forecast to 2028 (US$ Thousand)
9.1.2.5.1 Russia: Infant, Child, and Maternal Probiotic Supplements Market, By Form
9.1.2.5.2 Russia: Infant, Child, and Maternal Probiotic Supplements Market, by End User
9.1.2.6 Rest of Europe: Europe Infant, Child, and Maternal Probiotic Supplements Market – Revenue and Forecast to 2028 (US$ Thousand)
9.1.2.6.1 Rest of Europe: Infant, Child, and Maternal Probiotic Supplements Market, By Form
9.1.2.6.2 Rest of Europe: Infant, Child, and Maternal Probiotic Supplements Market, by End User
10. Industry Landscape
10.1 Overview
10.2 Product launch
10.3 Expansion
11. Company Profiles
11.1 Bayer Corporation
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Nestlé S.A.
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 BioGaia AB
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Nordic Naturals
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
12. Appendix
12.1 About The Insight Partners
12.2 Word Index
LIST OF TABLES
Table 1. Europe Infant, Child, and Maternal Probiotic Supplements Market –Revenue and Forecast to 2028 (US$ Thousand)
Table 2. Europe: Infant, Child, and Maternal Probiotic Supplements Market, By Form – Revenue and Forecast to 2028 (US$ Thousand)
Table 3. Europe: Infant, Child, and Maternal Probiotic Supplements Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)
Table 4. Germany Infant, Child, and Maternal Probiotic Supplements Market, By Form – Revenue and Forecast to 2028 (US$ Thousand)
Table 5. Germany Infant, Child, and Maternal Probiotic Supplements Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)
Table 6. UK Infant, Child, and Maternal Probiotic Supplements Market, By Form – Revenue and Forecast to 2028 (US$ Thousand)
Table 7. UK Infant, Child, and Maternal Probiotic Supplements Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)
Table 8. France Infant, Child, and Maternal Probiotic Supplements Market, By Form – Revenue and Forecast to 2028 (US$ Thousand)
Table 9. France Infant, Child, and Maternal Probiotic Supplements Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)
Table 10. Italy Infant, Child, and Maternal Probiotic Supplements Market, By Form – Revenue and Forecast to 2028 (US$ Thousand)
Table 11. Italy Infant, Child, and Maternal Probiotic Supplements Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)
Table 12. Russia Infant, Child, and Maternal Probiotic Supplements Market, By Form – Revenue and Forecast to 2028 (US$ Thousand)
Table 13. Russia Infant, Child, and Maternal Probiotic Supplements Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)
Table 14. Rest of Europe Infant, Child, and Maternal Probiotic Supplements Market, By Form – Revenue and Forecast to 2028 (US$ Thousand)
Table 15. Rest of Europe Infant, Child, and Maternal Probiotic Supplements Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)
Table 16. List of Abbreviation
LIST OF FIGURES
Figure 1. Europe Infant, Child, and Maternal Probiotic Supplements Market Segmentation
Figure 2. Europe Infant, Child, and Maternal Probiotic Supplements Market Segmentation – By Country
Figure 3. Europe Infant, Child, and Maternal Probiotic Supplements Market Overview
Figure 4. Europe Infant, Child, and Maternal Probiotic Supplements Market: By Form
Figure 5. Europe Infant, Child, and Maternal Probiotic Supplements Market: By Country
Figure 6. Porter’s Five Forces Analysis: Infant, Child, and Maternal Probiotic Supplements Market
Figure 7. Expert Opinion
Figure 8. Ecosystem: Europe Infant, Child, and Maternal Probiotic Supplements Market
Figure 9. Europe Infant, Child, and Maternal Probiotic Supplements Market Impact Analysis of Drivers and Restraints
Figure 10. Europe: Europe Infant, Child, and Maternal Probiotic Supplements Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 11. Europe: Europe Infant, Child, and Maternal Probiotic Supplements Market Revenue Share, By Form (2021 and 2028)
Figure 12. Capsules and Softgels: Europe Infant, Child, And Maternal Probiotic Supplements Market – Revenue and Forecast To 2028 (US$ Thousand)
Figure 13. Gummies: Europe Infant, Child, And Maternal Probiotic Supplements Market – Revenue and Forecast To 2028 (US$ Thousand)
Figure 14. Liquid: Europe Infant, Child, And Maternal Probiotic Supplements Market – Revenue and Forecast To 2028 (US$ Thousand)
Figure 15. Others: Europe Infant, Child, And Maternal Probiotic Supplements Market– Revenue and Forecast To 2028 (US$ Thousand)
Figure 16. Europe: Europe Infant, Child, and Maternal Probiotic Supplements Market Revenue Share, by End User (2021 and 2028)
Figure 17. Infant and Toddler: Europe Infant, Child, And Maternal Probiotic Supplements Market – Revenue and Forecast To 2028 (US$ Thousand)
Figure 18. Children: Europe Infant, Child, And Maternal Probiotic Supplements Market – Revenue and Forecast To 2028 (US$ Thousand)
Figure 19. Maternal Women: Europe Infant, Child, And Maternal Probiotic Supplements Market – Revenue and Forecast To 2028 (US$ Thousand)
Figure 20. Europe: Europe Infant, Child, and Maternal Probiotic Supplements Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 21. Europe: Europe Infant, Child, and Maternal Probiotic Supplements Market Revenue Share, by Key Country (2021 and 2028)
Figure 22. Germany: Europe Infant, Child, and Maternal Probiotic Supplements Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 23. UK: Europe Infant, Child, and Maternal Probiotic Supplements Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 24. France: Europe Infant, Child, and Maternal Probiotic Supplements Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 25. Italy: Europe Infant, Child, and Maternal Probiotic Supplements Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 26. Russia: Europe Infant, Child, and Maternal Probiotic Supplements Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 27. Rest of Europe: Europe Infant, Child, and Maternal Probiotic Supplements Market – Revenue and Forecast to 2028 (US$ Thousand)
● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe Infant, Child, and Maternal Probiotic Supplements Market.
● Highlights key business priorities in order to assist companies to realign their business strategies.
● The key findings and recommendations highlight crucial progressive industry trends in Europe Infant, Child, and Maternal Probiotic Supplements Market, thereby allowing players across the value chain to develop effective long-term strategies.
● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
● Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the market, as well as those hindering it.
● Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
The List of Companies – Europe Infant, Child, and Maternal Probiotic Supplements Market
● Bayer Corporation
● Nestlé S.A.
● BioGaia AB
● Nordic Naturals
At 8.2% CAGR, the Europe Infant, Child, and Maternal Probiotic Supplements Market is speculated to be worth US$ 287.30 million by 2028, says The Insight Partners
According to The Insight Partners’ research, the Europe infant, child, and maternal probiotic supplements market was valued at US$ 179.18 million in 2022 and is expected to reach US$ 287.30 million by 2028, registering an annual growth rate of 8.2% from 2022 to 2028. Rising demand for probiotic supplements in pediatric nutrition and growing awareness regarding benefits of probiotic supplements among pregnant women are the critical factors attributed to the market expansion.
Apart from having a wholesome diet, pregnant women are seeking various alternatives to support their fitness and the health of their unborn babies. Digestive problems, such as constipation, diarrhea, acidity, and inflammation, are common during pregnancy. Probiotic supplements can help in battling these issues, ensuring a healthy gut. A mother’s microbiome is believed to be crucial in maintaining her and her baby’s health. An infant is exposed to thousands of microbes while passing through the birth canal. Therefore, mothers must have a diet full of good bacteria to transfer to the newborn. Recently, probiotic dietary supplements for pregnant women have witnessed a high demand. Probiotic supplementation during pregnancy has several benefits. A thoroughly researched probiotic strains help improve bowel movement and relieve constipation problems. Studies have proven that including probiotic supplements in the regular diet of a pregnant woman help reduce inflammation, acidity, and bloating. Consumption of probiotic supplements during pregnancy also reduces the risk of vaginal infections, decreasing the chances of colic, eczema, and other allergies in newborn babies. Additionally, probiotics lower the risk of pre-eclampsia in pregnant women, a health condition resulting in high blood pressure and high protein levels in urine. Probiotic supplements also ensure better immunity for pregnant women, which helps fight chronic diseases and ensure good health of the baby. Lactobacillus acidophilus, Bifidobacterium bifidum, and Saccharomyces boulardii are among the most effective and widely used probiotic strains in prenatal probiotic supplements. These strains help to maintain a healthy intestinal flora and reduce the risk of various allergies, diseases, and complications, including gestational diabetes and pre-eclampsia. The growing awareness about the benefits of probiotic supplements among pregnant women is substantially driving the infant, child, and maternal probiotic supplements market.
On the contrary, consumer perceptions on probiotic supplements for newborn hampers market Europe infant, child, and maternal probiotic supplements market.
Based on form market is segmented into capsules and soft gels, gummies, liquid, and others. The others segment held 41.85% market share in 2022, amassing US$ 74.99 million. It is projected to garner US$ 119.06 million by 2028 to expand at 8.0% CAGR during 2022–2028.
Based on end user, the Europe infant, child, and maternal probiotic supplements market is segmented into into infant and toddler, children, and maternal women. The children segment held 61.67% market share in 2022, amassing US$ 110.58 million. It is projected to garner US$ 175.29 million by 2028 to expand at 8.0% CAGR during 2022–2028.
Based on country, the Europe infant, child, and maternal probiotic supplements market has been categorized into Germany, UK, France, Italy, Russia and Rest of Europe. Our regional analysis states that Rest of Europe captured 44.10% market share in 2022. It was assessed at US$ 79.01 million in 2022 and is likely to hit US$ 121.58 million by 2028, exhibiting a CAGR of 7.4% during the forecast period.
Key players dominating the Europe infant, child, and maternal probiotic supplements market are Bayer Corporation; Nestlé S.A.; BioGaia AB and Nordic Naturals.
In 2022; Bayer Vietnam launched the prenatal multivitamin made in France for women planning for pregnancy, pregnant, and breastfeeding. Elevit brand help mothers to meet their increased nutritional needs pre, during and after pregnancy, ensuring a healthy pregnancy. In 2022; BioGaia launched BioGaia Pharax, which aimed to strengthen the immune system and support children’s upper respiratory health. BioGaia created the product as a probiotic complement to normal analgesics.
Related Reports
- $3,000.00 – $5,000.00
